Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Wave Life Sciences, Inc. WVE

Full chart Compare
Set alert

Price alert · WVE

All alert types
3.62 USD +0.04 (+1.12%)

At closeNov 5, 2026, 7:30 AM EST

3.67 +0.05 +1.38%

Pre-market · Nov 5, 7:30 AM ET

3.56 Day range 3.78
3.04 52-week range 21.73
YTD
-78.71%
1 year
-54.81%

Financial health

Altman Z-Score

-0.35 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 4

Valuation

P/E -14.0×
FY 2016: -10.8×FY 2017: -9.1×FY 2018: -8.3×FY 2019: -1.5×FY 2020: -2.1×FY 2021: -1.3×FY 2022: -3.4×FY 2023: -9.4×FY 2024: -17.7×FY 2025: -14.0×
FY 2016 5y median -9.4× FY 2025
P/S 67.1×
FY 2016: 402×FY 2017: 251×FY 2018: 84.5×FY 2019: 17.0×FY 2020: 15.4×FY 2021: 4.0×FY 2022: 151×FY 2023: 4.7×FY 2024: 15.8×FY 2025: 67.1×
FY 2016 5y median 15.8× FY 2025
P/B 5.4×
FY 2016: 4.4×FY 2017: 6.7×FY 2018: 16.6×FY 2019: 3.8×FY 2020: 3.4×FY 2021: 5.0×FY 2022: -12.2×FY 2023: 13.5×FY 2024: 8.2×FY 2025: 5.4×
FY 2016 5y median 5.4× FY 2025
P/FCF -15.3×
FY 2016: -15.9×FY 2017: -9.1×FY 2018: -37.1×FY 2019: -1.4×FY 2020: -2.6×FY 2021: -1.8×FY 2022: -4.3×FY 2023: -26.1×FY 2024: -11.3×FY 2025: -15.3×
FY 2016 5y median -11.3× FY 2025
EV/EBITDA -11.7×
FY 2016: -8.1×FY 2017: -7.9×FY 2018: -6.8×FY 2019: -0.8×FY 2020: -1.1×FY 2021: -0.4×FY 2022: -3.3×FY 2023: -7.5×FY 2024: -16.2×FY 2025: -11.7×
FY 2016 5y median -7.5× FY 2025
EV/Sales 53.4×
FY 2016: 300×FY 2017: 214×FY 2018: 73.1×FY 2019: 9.8×FY 2020: 7.6×FY 2021: 1.0×FY 2022: 137×FY 2023: 3.2×FY 2024: 13.2×FY 2025: 53.4×
FY 2016 5y median 13.2× FY 2025
FCF Yield -6.5%
FY 2016: -6.3%FY 2017: -11.0%FY 2018: -2.7%FY 2019: -70.7%FY 2020: -38.0%FY 2021: -55.0%FY 2022: -23.4%FY 2023: -3.8%FY 2024: -8.9%FY 2025: -6.5%
FY 2016 5y median -8.9% FY 2025

Profitability

Gross Margin 79.3%
FY 2016: 73.5%FY 2017: -2041.2%FY 2018: -832.6%FY 2019: -997.6%FY 2020: -552.2%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 79.3%
FY 2016 5y median 100.0% FY 2025
Operating Margin -504.1%
FY 2016: -3725.7%FY 2017: -2769.4%FY 2018: -1106.7%FY 2019: -1303.4%FY 2020: -763.9%FY 2021: -310.1%FY 2022: -4459.3%FY 2023: -60.0%FY 2024: -101.9%FY 2025: -504.1%
FY 2016 5y median -310.1% FY 2025
Net Margin -478.3%
FY 2016: -3730.7%FY 2017: -2754.7%FY 2018: -1017.4%FY 2019: -1211.5%FY 2020: -746.7%FY 2021: -298.4%FY 2022: -4434.7%FY 2023: -50.8%FY 2024: -89.6%FY 2025: -478.3%
FY 2016 5y median -298.4% FY 2025
ROE -38.8%
FY 2016: -41.1%FY 2017: -73.0%FY 2018: -199.9%FY 2019: -270.4%FY 2020: -165.4%FY 2021: -376.2%FY 2022: 358.9%FY 2023: -145.1%FY 2024: -46.3%FY 2025: -38.8%
FY 2016 5y median -46.3% FY 2025
ROIC -39.0%
FY 2016: -36.2%FY 2017: -63.1%FY 2018: -94.8%FY 2019: -123.0%FY 2020: -94.2%FY 2021: -85.8%FY 2022: -202.5%FY 2023: -70.6%FY 2024: -44.4%FY 2025: -39.0%
FY 2016 5y median -70.6% FY 2025
ROA -32.0%
FY 2016: -33.6%FY 2017: -56.1%FY 2018: -49.6%FY 2019: -68.1%FY 2020: -53.7%FY 2021: -59.1%FY 2022: -110.5%FY 2023: -20.9%FY 2024: -27.5%FY 2025: -32.0%
FY 2016 5y median -32.0% FY 2025

Growth (YoY)

Revenue -60.5%
FY 2016: 877.0%FY 2017: 149.4%FY 2018: 289.1%FY 2019: 10.9%FY 2020: 25.6%FY 2021: 104.0%FY 2022: -91.1%FY 2023: 3005.1%FY 2024: -4.4%FY 2025: -60.5%
FY 2016 FY 2025
Operating Income -95.1%
FY 2016: -186.7%FY 2017: -85.4%FY 2018: -55.5%FY 2019: -30.6%FY 2020: 26.4%FY 2021: 17.2%FY 2022: -28.1%FY 2023: 58.2%FY 2024: -62.4%FY 2025: -95.1%
FY 2016 FY 2025
EPS (diluted) -72.9%
FY 2016: -173.0%FY 2017: -58.4%FY 2018: -31.4%FY 2019: -4.7%FY 2020: 27.9%FY 2021: 38.2%FY 2022: 13.1%FY 2023: 73.7%FY 2024: -29.6%FY 2025: -72.9%
FY 2016 FY 2025
Free Cash Flow -23.4%
FY 2016: -160.3%FY 2017: -173.9%FY 2018: 68.0%FY 2019: -485.8%FY 2020: 38.9%FY 2021: 23.7%FY 2022: -44.2%FY 2023: 84.1%FY 2024: -639.6%FY 2025: -23.4%
FY 2016 FY 2025

Financial Health

Current Ratio 6.5×
FY 2016: 12.5×FY 2017: 7.7×FY 2018: 1.6×FY 2019: 1.6×FY 2020: 1.9×FY 2021: 2.5×FY 2022: 1.4×FY 2023: 1.3×FY 2024: 2.9×FY 2025: 6.5×
FY 2016 5y median 2.5× FY 2025
Quick Ratio 6.5×
FY 2016: 12.5×FY 2017: 7.7×FY 2018: 1.6×FY 2019: 1.6×FY 2020: 1.9×FY 2021: 2.5×FY 2022: 1.4×FY 2023: 1.3×FY 2024: 2.9×FY 2025: 6.5×
FY 2016 5y median 2.5× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.1×FY 2019: 0.5×FY 2020: 0.3×FY 2021: 0.9×FY 2022: -0.8×FY 2023: 0.8×FY 2024: 0.1×FY 2025: 0.0×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 3.0×
FY 2016: 2.7×FY 2017: 1.4×FY 2018: 1.1×FY 2019: 0.6×FY 2020: 1.1×FY 2021: 1.1×FY 2022: 0.3×FY 2023: 3.4×FY 2024: 3.1×FY 2025: 3.0×
FY 2016 5y median 3.0× FY 2025
Interest Coverage 0.0×
FY 2016: -164×FY 2017: -17097×FY 2018: -7251×FY 2019: 0.0×FY 2020: -9586×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31